Search by Drug Name or NDC

    NDC 16110-0246-30 Seysara 100 mg/1 Details

    Seysara 100 mg/1

    Seysara is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Almirall, LLC. The primary component is SARECYCLINE HYDROCHLORIDE.

    Product Information

    NDC 16110-0246
    Product ID 16110-246_d2bf5f32-46e1-4c89-a271-45054f69ff7d
    Associated GPIs 04000057100330
    GCN Sequence Number 079079
    GCN Sequence Number Description sarecycline HCl TABLET 100 MG ORAL
    HIC3 W1C
    HIC3 Description TETRACYCLINE ANTIBIOTICS
    GCN 45511
    HICL Sequence Number 045331
    HICL Sequence Number Description SARECYCLINE HCL
    Brand/Generic Brand
    Proprietary Name Seysara
    Proprietary Name Suffix n/a
    Non-Proprietary Name sarecycline hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name SARECYCLINE HYDROCHLORIDE
    Labeler Name Almirall, LLC
    Pharmaceutical Class P-Glycoprotein Inhibitors [MoA], Tetracycline-class Drug [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209521
    Listing Certified Through 2024-12-31

    Package

    NDC 16110-0246-30 (16110024630)

    NDC Package Code 16110-246-30
    Billing NDC 16110024630
    Package 30 TABLET, COATED in 1 BOTTLE (16110-246-30)
    Marketing Start Date 2019-01-04
    NDC Exclude Flag N
    Pricing Information N/A